Athenex's Unattributed - II Round

Athenex raised a round of funding on December 23, 2013.

Athenex (NASDAQ: ATNX), formerly Kinex Pharmaceuticals, is a global oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases an…

Articles about Athenex's Unattributed - II Round: